Skip to main content
Log in

Predictors of AA amyloidosis in familial Mediterranean fever

  • Short Communication - Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of the study was to evaluate the clinical and genetic predictors of AA amyloidosis in patients with familial Mediterranean fever (FMF). We retrospectively studied 170 Armenian patients who were admitted to the two tertiary centers in 2003–2014. The diagnosis of amyloidosis that was suspected clinically (new proteinuria or nephrotic syndrome) was confirmed histologically. Screening for MEFV gene mutations was performed in 70 patients. The most common genotype was M694V/M694V (in 36 % of patients). Biopsy-proven AA amyloidosis was found in 102 (60 %) of 170 patients. AA amyloidosis was diagnosed in 17 (68 %) of 25 patients with homozygous M694V mutation, 17 (53 %) of 32 patients with heterozygous M694V allele and 4 (31 %) of 13 patients with other MEFV gene mutations. The M694V homozygosity and heterozygosity were associated with increased risk of AA amyloidosis, but this association did not reach statistical significance (odds ratio 2.43; 95 % CI 0.87–6.76, and 3.33; 0.91–12.1, respectively). Male gender, early onset of disease, severity of FMF, frequent attacks, peritonitis, pleuritis and erysipelas-like erythema also did not predict AA amyloidosis development. Recurrent arthritis was the only clinical finding that was significantly associated with AA amyloidosis (odds ratio 2.28; 95 % CI 1.17–4.42). Involvement of the joint synovial membrane, that is capable of active serum amyloid A production, is the main predictor of renal amyloidosis in FMF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27:621–668

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797–807

    Article  Google Scholar 

  3. Dewalle HJ, Domingo C, Rosenbaum M, Ben-Chetrit E, Cattan D, Bernot A, Dross C, Dupont M, Notarnicola C, Levy M, Rosner I, Demaille J, Touitou I (1998) Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever. Eur J Hum Genet 6:95–97

    Article  CAS  PubMed  Google Scholar 

  4. Shohat M, Magal N, Shohat T, Chen X, Dagan T, Miomouni A, Danon Y, Lotan R, Ogur G, Sirin A, Schlenzinger M, Halpern GJ, Schwabe A, Kastner D, Rotter JI, Fischel-Ghodsian N (1999) Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 7:287–292

    Article  CAS  PubMed  Google Scholar 

  5. Ben-Chetrit E, Backenroth R (2001) Amyloidosis induced, end stage renal disease in patients with renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum 60:146–149

    Article  CAS  Google Scholar 

  6. Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentiewich I, Koziol DE, Kastner DL, Pras M, Pras E (2000) Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 27:1703–1707

    CAS  PubMed  Google Scholar 

  7. Kasifoglu T, Bilge SY, Sari I et al (2014) Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology (Oxford) 53(4):741–745

    Article  Google Scholar 

  8. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A (2003) The contribution of genotype at MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48:1149–1155

    Article  PubMed  Google Scholar 

  9. French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31

    Article  Google Scholar 

  10. Yalçinkaya F, Cakar N, Misirlioğlu M, Tümer N, Akar N, Tekin M, Taştan H, Koçak H, Ozkaya N, Elhan AH (2000) Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology 39:67–72

    Article  PubMed  Google Scholar 

  11. Cazeneuve C, Sarkisian T, Pêcheux C, Dervichian M, Nédelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dodé C, Grateau G, Amselem S (1999) MEFV-gene analysis in armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65(1):88–97

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885

    Article  CAS  PubMed  Google Scholar 

  13. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, Kastner DL (1998) Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the national institutes of health. Medicine 77:268–297

    Article  CAS  PubMed  Google Scholar 

  14. Touitou I, Sarkisian T, Medlej-Hashim M et al (2006) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56:1706–1712

    Article  Google Scholar 

  15. Grateau G (2004) Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology 43:410–415

    Article  CAS  PubMed  Google Scholar 

  16. Rameev VV, Kozlovskaia LV, Malinina EA, Serova AG, Kogarko IN, Kogarko BS, Liubimova NV (2011) Current methods of systemic amyloidosis diagnosis and monitoring of its course. Ter Arkh 83(8):48–54

    CAS  PubMed  Google Scholar 

  17. Saatçi U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623

    Article  PubMed  Google Scholar 

  18. Zaks N, Shinar Y, Padeh S, Lidar M, Mor A, Tokov I, Pras M, Langevitz P, Pras E, Livneh A (2003) Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J 5:585–588

    CAS  PubMed  Google Scholar 

  19. Gershoni-Baruch R, Brik R, Shinawi M, Lidar M, Livneh A (2003) Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in familial Mediterranean fever patients homozygous for the M694V-MEFV mutation. J Rheumatol 30:308–312

    PubMed  Google Scholar 

  20. O’Hara R, Murphy EP, Whitehead AS, FitzGerald O, Bresnihan B (2000) Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res 2:142–148

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergey V. Moiseev.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mukhin, N.A., Kozlovskaya, L.V., Bogdanova, M.V. et al. Predictors of AA amyloidosis in familial Mediterranean fever. Rheumatol Int 35, 1257–1261 (2015). https://doi.org/10.1007/s00296-014-3205-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-3205-x

Keywords

Navigation